Executive Overview The landscape of modern immuno-oncology is shifting once again, driven by a novel class of bispecific antibodies designed...
Executive Overview The landscape of modern therapeutics is constantly shaped by milestones that redefine what is possible in clinical research....
Executive Overview In a significant milestone for cardiovascular therapeutics, Milestone Pharmaceuticals has officially announced the dosing of the first patient...
Executive Overview The landscape of immuno-oncology has long been defined by the pursuit of combination therapies and multi-targeted biologic agents...
Executive Overview The landscape of obesity pharmacotherapy is undergoing a seismic shift. For years, the gold standard in incretin-based therapeutics...
Executive Overview In a significant milestone for next-generation oncology drug development, biopharmaceutical innovator Akeso has announced the successful dosing of...
Executive Overview In a significant milestone for metabolic therapeutics, biopharmaceutical innovator Neurocrine Biosciences has officially commenced a Phase I clinical...
Executive Overview For over a century, the foundational ethos of clinical training has relied on the intuition famously captured by...
Executive Overview In a significant strategic expansion of its oncology clinical development pipeline, Summit Therapeutics has announced the initiation of...
Executive Overview In a significant milestone for modern oncology and the evolution of cell-based immunotherapies, clinical-stage biopharmaceutical company Dispatch Bio...
Executive Overview In the high-stakes world of biopharmaceutical research, the line separating scientific innovation from investor skepticism is razor-thin. On...
Executive Overview In a major development for the clinical advancement of genetic medicines targeting rare muscle disorders, biotechnology innovator PepGen...
